Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol-N versus Custodiol for pediatric heart transplant organ perfusion
2023-510492-57-00Phase 2Authorised
- Sponsor
- Franz Köhler Chemie
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in Cardiovascular Malformation (CVM) and heart failure (HF) comparing Custodiol-N with Custodiol (2 arms). Primary endpoint: Safety assessment. Planned start Sep 2023; status: authorised.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)HTK Custodiol
03
Conditions
Cardiovascular Malformation (CVM)heart failure (HF)
Beyond the preview
Go deeper on 2023-510492-57-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510492-57-00.